Look at a real-world study of blood-based Alzheimer's biomarkers and how clinicians used those results to change diagnoses and care.
Key Takeaways
- Blood test measuring amyloid-beta and phosphorylated tau raised diagnostic accuracy to about ninety percent
- Primary care physicians reached specialist-level diagnostic accuracy after testing
- Clinicians changed diagnoses for about one-third of patients and revised management in roughly half of cases